Point of Care Nano-Technology, Inc. (PCNT) Financial Statements (2024 and earlier)

Company Profile

Business Address 109 AMBERSWEET ROAD
DAVENPORT, FL 33897
State of Incorp.
Fiscal Year End July 31
Industry (SIC) 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

4/30/2023
MRQ
1/31/2023
MRQ
7/31/2022
7/31/2015
7/31/2014
7/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments7341770
Cash and cash equivalents7341770
Prepaid expense33   
Total current assets:10641770
Noncurrent Assets
Intangible assets, net (including goodwill)121123  
Intangible assets, net (excluding goodwill)121123   
Other undisclosed noncurrent assets 0    
Total noncurrent assets:121123   
TOTAL ASSETS:13113041770
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities236213124234
Interest and dividends payable124 
Accounts payable236213   
Accounts payable and other accrued liabilities234
Debt   952626
Due to related parties    100 
Total current liabilities:236213107130260
Noncurrent Liabilities
Other undisclosed liabilities   21421912
Total liabilities:236213320349272
Equity
Equity, attributable to parent, including:(105)(84)(316)(172)(272)
Preferred stock00   
Common stock11422
Treasury stock, value (1)(1)   
Additional paid in capital120,192120,192119,7431,087798
Accumulated deficit(120,317)(120,276)(120,063)(1,261) 
Other undisclosed equity, attributable to parent20   (1,072)
Total equity:(105)(84)(316)(172)(272)
TOTAL LIABILITIES AND EQUITY:13113041770

Income Statement (P&L) ($ in thousands)

4/30/2023
TTM
1/31/2023
TTM
7/31/2022
7/31/2015
7/31/2014
7/31/2013
Revenues 100100   
Revenues, excluding interest and dividends  100   
Gross profit: 100100   
Operating expenses(59)(74)(118,782)(185)(118)
Operating income (loss):4126(118,782)(185)(118)
Nonoperating income (expense)  10  (128)
Investment income, nonoperating  10   
Interest and debt expense   (20)(4)(10)
Other undisclosed income from continuing operations before equity method investments, income taxes10    
Income (loss) from continuing operations:5136(118,802)(189)(256)
Income (loss) before gain (loss) on sale of properties:6436(118,802)(189)(256)
Net income (loss):5136(118,802)(189)(256)
Other undisclosed net income (loss) attributable to parent(100)(100)  128
Net loss available to common stockholders, diluted:(49)(64)(118,802)(189)(128)

Comprehensive Income ($ in thousands)

4/30/2023
TTM
1/31/2023
TTM
7/31/2022
7/31/2015
7/31/2014
7/31/2013
Net income (loss):5136(118,802)(189)(256)
Comprehensive income (loss), net of tax, attributable to parent:5136(118,802)(189)(256)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: